The Russian developer of the online digital therapy platform for people with chronic illnesses,, has attracted investment of 307 million rubles from Kama Flow and investors from the Syndicate Venture Club. This was announced to RB.RU by the founder and CEO of, Eric Brovko. raised 307 million rubles to expand services for doctors and launch subscriptions to premium products

According to him, the investments will be used to expand the number of nosologies and support services for doctors and patients using medical devices, as well as to launch a subscription to premium healthcare services.

Kama Flow became the lead investor in the round, investors from the Syndicate venture club, including the club’s CEO Vyacheslav Shulenin, Avito CFO Sergey Piven, Angelsdeck co-founder Sergey Dashkov, and others, also participated in the agreement. Kama Flow’s acquired stake is not disclosed.

Kama Flow expects that by 2026 will be able to increase revenue 10 times by launching a B2C subscription and developing the digital therapy market in Russia (according to the Kontur.Focus system, the service’s revenue in 2021 amounted to 79 million rubles). .

  • is a digital therapy platform for people with chronic diseases. Digital therapy is a treatment method that uses digital services (medication management, diaries and symptom analysis with device integration, education, community, AI physician assistant, meditation, doctor appointment, etc.), which have as aim to change behavior and culture. of a person’s relationship with their health.
  • Such services are developed on the principles of evidence-based medicine and undergo research to demonstrate medical and economic effect. Now, the platform combines a patient’s mobile app, a doctor’s app, and an analytics platform for aggregated anonymous medical data. was founded in 2016, during which time it has developed at the expense of the founder’s own funds and investments from informal investors. In February 2022, the company announced that it was raising RUB 135 million from the Medsi chain of clinics at an estimated RUB 1.1 billion, however, by agreement of the parties, the deal was frozen and subsequently terminated.

“The main reason was the temporary suspension of venture capital transactions due to increased risks due to market turmoil. Today, and Medsi maintain partnership and friendship relations,” Brovko said.

Currently, more than 10 pharmaceutical companies are working with the project, including J&J, Roche, Sanofi, AstraZeneca Takeda, Dr Reddy’s, OlainFarm, and 3000 specialists have already joined the new product Vrach launched in the summer. The number of patients exceeds 600 thousand people.


anastasia mariana

Source: RB

Previous articleIs it safe to buy mobile phones from Mercado Livre?
Next articleWatched Money Shot: The Story of Pornhub by Netflix. Here is an assessment of all the dirt of the porn industry (18+)
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.


Please enter your comment!
Please enter your name here